The “Inflation Reduction Act:” A Deceptive Attempt to Push Liberal Policy at All Costs
CASE Issues Statement Rebuking House Democrats for their Reckless Approval of the Falsely-Titled “Inflation Reduction Act” August 12, 2022...
CASE Issues Statement on Senate Democrats’ Assault on America’s Healthcare System
August 9, 2022 Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement denouncing...
CASE Op-Ed – RealClearHealth: Biden Administration Is Using Inflation to Masquerade Their Drug Pricing Schemes
July 26, 2022 The midterms are less than five months away, and with President Biden’s approval numbers at a historic...
CASE Issues Statement & Letter to Senate on Danger of Democrats’ Latest Drug Pricing Plan
July 21, 2022 Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement and...
Democrats’ Drug Pricing Plan: A Step in the Wrong Direction for America’s Seniors
July 6, 2022 After months and months of petty negotiations over Build Back Better, Democrats have finalized a dangerous...
CASE Sends Letter to Key House Leaders Urging Passage of Innovative MARCA Legislation
June 9 ,2022 CASE today sent a letter to the Chairpersons and Ranking Members of key House committees urging...
Posting Drug Prices in TV Ads Would Be a Mistake
May 12, 2022 A well-intentioned but ineffective proposal that would force drug manufacturers to post the price of prescription...
CASE Letter to Senate Leaders Makes Devastating Case Against Drug Importation Plans
May 11, 2022 Dear Senate Leaders, In spite of well-founded fears about the safety and effectiveness of allowing states to...
CASE Op-ed – RealClear Health: Innovative, Pro-Patient MARCA Legislation Deserves Congressional Action
April 13, 2022 It would seem that any policy innovation that could lower healthcare costs, expand access, provide better care,...
Patients Deserve Stronger Patent Protections
April 12, 2022 Pandemic or not, millions of Americans heavily depend on lifesaving treatments. Thanks to America’s cutting-edge healthcare system...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/